RGLEX | RWIBX | RGLEX / RWIBX | |
Total Expense Ratio | 0.80 | 1.51 | 53% |
Annual Report Gross Expense Ratio | 0.80 | 1.51 | 53% |
Fund Existence | 5 years | 23 years | - |
Gain YTD | 1.201 | 0.311 | 386% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.3B | 122B | 13% |
Annual Yield % from dividends | 0.89 | 0.92 | 97% |
Returns for 1 year | 5.15 | -0.79 | -652% |
Returns for 3 years | 18.84 | 10.11 | 186% |
Returns for 5 years | 80.18 | 61.13 | 131% |
Returns for 10 years | N/A | 37.73 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NZF | 12.35 | 0.12 | +0.98% |
Nuveen Municipal Credit Income Fund | |||
FICS | 36.82 | 0.18 | +0.49% |
First Trust Intl Developed Cap Strth ETF | |||
VEGA | 43.18 | 0.17 | +0.40% |
AdvisorShares STAR Global Buy-Write ETF | |||
FMAT | 48.50 | 0.18 | +0.37% |
Fidelity MSCI Materials ETF | |||
CNCR | 9.00 | -0.43 | -4.56% |
Range Cancer Therapeutics ETF |